Renaissance Technologies - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 71 filers reported holding UNITY BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2022$625,000
+15.7%
1,582,369
+65.2%
0.00%0.0%
Q2 2022$540,000
-46.9%
957,718
+5.6%
0.00%0.0%
Q1 2022$1,016,000
-35.4%
906,715
-15.9%
0.00%
-50.0%
Q4 2021$1,573,000
-18.2%
1,077,700
+68.2%
0.00%0.0%
Q3 2021$1,922,000
-19.2%
640,700
+25.0%
0.00%
-33.3%
Q2 2021$2,378,000
-2.5%
512,600
+82.5%
0.00%
+50.0%
Q2 2020$2,438,000
+190.9%
280,900
+94.5%
0.00%
+100.0%
Q1 2020$838,000
+288.0%
144,400
+381.3%
0.00%
Q4 2019$216,00030,0000.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Founders Fund V Management, LLC 491,751$275,0002.22%
GSA CAPITAL PARTNERS LLP 639,937$361,0000.05%
PURA VIDA INVESTMENTS, LLC 359,089$202,0000.01%
Caption Management, LLC 725,000$409,0000.01%
Forefront Analytics, LLC 20,377$11,0000.01%
Johnson Midwest Financial, LLC 6,100$3,0000.00%
Virtu Financial LLC 62,640$35,0000.00%
Caption Management, LLC 225,000$127,0000.00%
SeaCrest Wealth Management, LLC 25,000$14,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 191,450$108,0000.00%
View complete list of UNITY BIOTECHNOLOGY INC shareholders